Local
US FDA orders blindness warning on Ozempic and other GLP-1 drugs
Meet in Common connects news with real conversations. Use ThinkMatch to arrange a Roundtable and meet people to discuss this story.
Source: Skardu Times

Makers of semaglutide and tirzepatide medicines must tell patients about NAION, a rare optic nerve disorder that can cause permanent vision loss in one eye.
This excerpt comes from the named source. Read the original for the full reporting.
Read the original at Skardu Times



